Startseite Lebenswissenschaften Evaluation of Quality of Life in Terms of Sinonasal Symptoms in Children with Cystic Fibrosis
Artikel Open Access

Evaluation of Quality of Life in Terms of Sinonasal Symptoms in Children with Cystic Fibrosis

  • Maryam Hassanzad , Kourosh Fakhimi Derakhshan , Hosseinali Ghaffaripour , Ali Safavi Naeini , Habib Emami und Ali Akbar Velayati
Veröffentlicht/Copyright: 17. Juni 2019

Abstract

Objective

Sinusitis is a common complaint in children with cystic fibrosis. However, the actual prevalence of chronic rhinosinusitis and its effect on the quality of life of children have not been well considered. Therefore, the objective of this study was to determine the effect of sinonasal quality of life in children with cystic fibrosis.

Materials and methods

This study was a diagnostic study performed on 80 children with cystic fibrosis ranging from 2 to 20 years old, who were referred to the cystic fibrosis clinic of Masih Daneshvari Hospital from 2017–2018. The questionnaires used in this study were chronic rhinosinusitis screening questionnaire based on the European task force and the evaluation of the sinonasal quality of life was based on the SN-5 survey.

Results

Of the 80 patients with fibrosis from 2 to 20 years old who were recruited in the study, 41 patients were female (51.3%) and 39 were male (48.8%). In 61 cases (76.3%), there was no chronic rhinosinusitis and 19 cases (23.8%) had chronic rhinosinusitis. The mean SN-5 score in 19 patients with chronic rhinosinusitis was 3.4105 and the mean score of patients without rhinosinusitis was 1.8426, with a P-value of 0.000. The mean SN-5 score was significant between the two groups. In patients with nasal congestion, there was a significant difference in quality of life factors such as sinus infection, nasal obstruction, and allergy symptoms (P<0.001). In patients with facial pain, there was a significant difference in quality of life factors such as sinus infection, nasal obstruction, allergic symptoms, and physical activity limitation (P <0.001). There was also a significant difference in the quality of life factors such as sinus infection, nasal obstruction, and allergy symptoms in patients with postnasal drip (P <0.001).

Conclusion

In children with cystic fibrosis, the quality of life of sinonasal has a significant relationship with absence of chronic rhinosinusitis. This study showed that children with chronic renosinusitis have significantly lower quality of sinonasal life than children with chronic rhinosinusitis. The results demonstrated that quality of life scores in sinus infections, nasal obstruction, and allergy symptoms were significantly higher in patients with chronic rhinosinusitis than in those without chronic rhinosinusitis. The findings of this study are important for improving children’s health related quality of life, as it leads to promoting communication between the patient and the health care provider, identifying overlooked problems, monitoring the progress of the disease and the burden of treatment, and promoting interventions in the daily life of patients.

Introduction

Cystic fibrosis is a multisystemic disorder in children and adolescents. The disease is the most common life-limiting congenital disorder in white people. Disruptions in the function of cystic fibrosis transmembrane conductance regulator, as a primary defect, leads to a wide range of symptoms and complications [1]. Cystic fibrosis is the most common cause of chronic pulmonary disease in children and is the leading cause of exocrine pancreatic insufficiency in early life. It also affects many cases of pansinusitis, nasal polyps, rectal prolapse, pancreatitis, cholelithiasis, and insulin-related hyperglycemia. It is considered in the differential diagnosis of many childhood diseases [2, 3].

In a study by Chan et al., sinonasal quality of life was evaluated in children with cystic fibrosis. Forty-seven children from ages 2 to 20 years old were recruited in the study. According to different diagnostic methods(American Rhinologic Society (ARS) guidelines), the rate of chronic rhinosinusitis in children with cystic fibrosis was 11% to 38%. According to SN-5 (Sinus and Nasal Quality of Life Survey), there were no significant changes in quality of life of children with history of sinusitis treatment before and after the treatment [4].

Cystic fibrosis patients are known to have physical symptoms associated with chronic sinusitis. They are also reported to have an almost constant increase in the thickness of mucoperiosteal based on CT scans, and nasal polyps are found in more than 48% of children with cystic fibrosis [5, 6]. However, the actual prevalence of chronic rhinosinusitis and its effect on the quality of life of children with cystic fibrosis is not well described. In one study, 10% of the children had sinonasal symptoms [7]; while in other studies, the prevalence of symptoms was up to 62% [8]. A study conducted on a group of children with cystic fibrosis by Sino-Nasal Outcome Test SNOT-16 test showed little effect on their quality of life compared to asymptomatic adults, but they had better quality of life than adults with chronic rhinosinusitis [9]. SN-5 is a valuable test in assessing the children’s quality of life [10].

In a study by Rudnick et al. on long-term improvement in postoperative quality of life in children with chronic rhinosinusitis, the children’s caregivers filled out the SN-5 questionnaire before and after the surgery. Out of all the 22 children with mean age of 5.7 years old, the mean score before surgery was 25.6 and after surgery was 11.7 in the short term, and 11.5 in the long term. The decrease was significant in both cases and reflected the long-term improvement in quality of life [11]. By increasing the longevity of patients, a series of new psychological issues were emerging, including affection, self-care, peer relationships, occupation, health concerns, and prognosis [3, 12, 13, 14].

Although the symptoms of sinusitis in children are rarely serious or life threatening, it is essential to measure these children’s quality of life. With the necessary medical and psychological support, children and adolescents with cystic fibrosis can be less likely to suffer from illness and will become active and independent in the middle age. Thus, the question is: What is the effect of chronic sinonasal problems on the quality of life of children with cystic fibrosis? Therefore, the objective of this study was to determine answer this question.

Materials and method

The present study was a diagnostic study which was conducted on 80 children with cystic fibrosis from 2 to 20 years old who were referred to cystic fibrosis clinic of Masih Daneshvari Hospital from 2017–2018. Patients were excluded if they had a nonroutine appointment in the clinic (such as acute ill patient).

The objectives of the study were first reported to patients and their parents, and then if they agreed to participate in the study, the questionnaire was given to them. The questionnaire consisted of three parts. The first part was related to the personal characteristics of patients, such as age and gender; the second part was related to the screening of chronic rhinosinusitis based on the European task force; and the third part was related to the assessment of the sinonasal quality of life based on the SN-5 form. The Sinonasal-5 (SN-5) is a validated pediatric sinonasal quality of life instrument. Each of the questions in SN-5 was scored from 1 to 7 (none of the time = 1, all of the time = 7). In this study, chronic pediatric rhinosinusitis was detected based on the presence of 2 or more of the following items for up to 12 weeks. The symptoms were nasal obstruction, nasal discharge, facial pain or pressure, and reduced sense of smell. Radiological and endoscopic examinations were not benchmarks. Data were analyzed by SPSS software version 25 using descriptive and inferential tests.

Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the Shahid Beheshti University of Medical Sciences Ethics Committee (IR.SBMU.NRITLD.REC.1396.446).

Informed consent: Informed consent has been obtained from all individuals included in this study.

Results

Results demonstrated that 41 subjects (51.3%) were female and 39 were male (48.8%). Sixty-one subjects (76.3%) had

no chronic rhinosinusitis and 19 (23.8%) had chronic rhinosinusitis. The mean SN-5 score in 19 patients with chronic rhinosinusitis was 3.4105 and the mean score of patients without rhinosinusitis was 1.8426, with a P-value of 0.000. The mean SN-5 score difference was statistically significant between the two groups (Table 1).

Table 1

Comparison of mean SN-5 in patients with chronic rhinosinusitis and those non-chronic rhinosinusitis in patients with cystic fibrosis referred to The Masih Daneshvari hospital from 2017–2018.

Chronic RhinosinusitisNMeanStd. DeviationStd. Error MeanMean RankP-value
SN-5 ScoreNo611.84260.797590.1021234.080.000
Yes193.41051.470410.3373461.11

The findings showed that in patients with nasal congestion, there was a significant difference in quality of life factors such as sinus infection, nasal obstruction, and allergy symptoms (P <0.001, Table 2).

Table 2

Comparison of quality of life scores between people with nasal obstruction and those no nasal obstructions using the Nonparametric Mann-Whitney U test.

Nasal Congestion or ObstructionNMeanMedianMean RankStd. DeviationP-value
Sinus InfectionNo612.692.0034.581.7850.000
Yes194.955.0059.501.747
Nasal ObstructionNo611.801.0033.251.3640.000
Yes194.264.0063.791.727
Allergy SymptomsNo611.661.0035.491.0780.000
Yes193.213.0056.581.873
Emotional DiscomfortNo611.701.0039.141.2690.269
Yes192.681.0044.872.562
Activity LimitationNo611.341.0038.770.9980.080
Yes192.001.0046.051.732
Schematic ScoreNo617.978.0040.521.7410.991
Yes197.478.0040.452.894

In patients with reduced sense of smell there was a significant difference in quality of life factors such as sinus infection, nasal obstruction, and allergic symptoms (P <0.001, Table 3).

Table 3

Comparison of quality of life scores between people with reduced sense of smell and those no reduced sense of smell using the Nonparametric Mann-Whitney U test.

Reduced Sense of SmellNMeanMedianMean RankStd. DeviationP-value
Sinus InfectionNo723.06338.691.960.033
Yes84.75656.811.98
Nasal ObstructionNo722.17137.941.640.002
Yes84.38663.562.00
Allergy SymptomsNo721.88138.961.290.049
Yes83.38454.382.20
Emotional DiscomfortNo721.85139.751.560.308
Yes82.75247.252.66
Activity LimitationNo721.47140.181.220.588
Yes81.75143.381.39
Schematic ScoreNo727.92841.372.060.303
Yes87.25732.692.12

There was a significant difference in the quality of life factors such as sinus infection, nasal obstruction, and allergy symptoms, and activity limitation in patients with facial pain, fullness, or pressure (P <0.05, Table 4).

Table 4

Comparison of quality of life scores between people with facial pain, fullness, or pressure and those no -facial pain, fullness, or pressure using the Nonparametric Mann-Whitney U test.

Facial Pain, Fullness, or PressureNMeanMedianMean RankStd. DeviationP-value
Sinus InfectionNo682.93337.431.840.004
Yes124.92657.922.19
Nasal ObstructionNo682.00136.671.400.000
Yes124.58662.212.19
Allergy SymptomsNo681.76137.531.130.003
Yes123.50457.332.15
Emotional DiscomfortNo681.66138.761.220.061
Yes123.50250.332.94
Activity LimitationNo681.32138.690.950.015
Yes122.50150.752.02
Schematic ScoreNo687.99841.351.860.426
Yes127.08835.712.94

The findings also depicted that there was a significant difference in the quality of life factors such as sinus infection, nasal obstruction, and allergy symptoms in patients with nasal discharge or postnasal drip (P <0.001, Table 5).

Table 5

Comparison of quality of life scores between people with Nasal Discharge or Postnasal Drip and without nasal Discharge or Postnasal Drip using the Nonparametric Mann-Whitney U test.

Nasal Discharge or PostnasalDripNMeanMedianMean RankStd. DeviationP-value
Sinus InfectionNo552.33230.571.520.000
Yes255.20662.341.50
Nasal ObstructionNo551.87134.941.310.001
Yes253.52452.742.18
Allergy SymptomsNo551.60135.020.970.001
Yes252.96352.561.88
Emotional DiscomfortNo551.62139.301.010.420
Yes252.64143.142.55
Activity LimitationNo551.25138.450.750.085
Yes252.04145.021.81
Schematic ScoreNo558.24843.441.540.085
Yes257.00834.042.75

Based on the SN-5 variables, sinus infection had the highest effect and activity limitation had the least effect on the quality of life (Table 6, Figure 1).

Table 6

Factor coefficient for determining SN-5 mean score.

MeanStd. DeviationPearson CorrelationP-valueStandardized Coefficients
SN-5 Score2.21501.19441
Sinus Infection3.232.0120.7820.0000.337
Nasal Obstruction2.391.7900.8130.0000.300
Emotional Discomfort1.941.7010.6810.0000.285
Allergy Symptoms2.031.4580.6450.0000.244
Activity Limitation1.501.2320.6840.0000.206
Figure 1 Factor coefficients for determining SN-5 mean score.
Figure 1

Factor coefficients for determining SN-5 mean score.

Discussion

The study aimed to demonstrate a small part of health related quality of life in patients with chronic cystic fibrosis after promoting its use in daily visits and practice. The findings showed that quality of life scores from sinus infection, nasal obstruction, and allergy symptoms in patients with nasal congestion were significantly higher than in those without nasal congestion. Nasal congestion occurs due to cold and sinus infections, which blocks the nasal bacteria and viruses and makes it harder to breathe. In most cases, this can be remedied within a week with medication and some topical treatments [12].

It should be noted that the quality of life scores for sinus infections, nasal obstruction, allergic symptoms, and activity limitation in patients with facial pain were significantly higher than in those with no facial pain. Nasal congestion, nasal discharges with changed color, and facial pain or pressure are the main symptoms of sinus infection that lasts for 7 days or more. When the sinuses become inflamed and swollen, they are no longer able to evacuate mucus, resulting in the patient feeling fullness and pain in the face [15].

In analyzing the determining factors for chronic rhinosinusitis, the findings suggested that the nasal

discharge factor in patients with cystic fibrosis and chronic rhinosinusitis was significantly associated with the sinonasal quality of life. In other words, there was a significant relationship between SN-5 components mean scores in nasal discharge and postnasal drip factors, so that patients with postnasal drip factor had higher scores of sinonasal quality of life. Often chronic inflammation in the nasal cavities leads to the swelling of inside the nose, which causes nasal obstruction and congestion. This status also plays a role in conducting fluids from the postnasal area into the throat and causes sputum [16]. Additionally, the purulent postnasal drip and nasal congestion are chronic sinusitis symptoms. The findings of this study also indicated that for evaluating factors affecting SN-5 scores, sinus infections had the highest coefficient compared to other factors. In other words, the sinus infection factor had the greatest effect on the determination of sinonasal quality of life. Friedman et al. evaluated the sinonasal quality of life and pulmonary function test in children with cystic fibrosis. In their study, the SNOT-16 questionnaire of sinonasal quality of life was used and compared with force expiratory volume FEV1. Children below 12 years old, there was a significant relationship between SNOT-16 and FEV1. Children with higher FEV1, had lower SNOT-16. The severity of sinus disease was associated with the severity of pulmonary disease in children with cystic fibrosis below 12 years old [9].

The findings of the present study suggested that in children with cystic fibrosis, the sinonasal quality of life had a significant association with chronic rhinosinusitis. According to the data analysis of this study, children with chronic rhinosinusitis had significantly reduced sinonasal quality of life compared to children who had not chronic rhinosinusitis. In a study conducted by Habib et al., the association between chronic rhinosinusitis and health related quality of life was investigated in patients with cystic fibrosis. In 113 patients with cystic fibrosis, the prevalence of chronic rhinosinusitis in patients older than 19 years old was 59.2%. Pulmonary function test did not show any significant difference between the two groups with and without chronic rhinosinusitis. However, patients with chronic rhinosinusitis had lower scores in assessing quality of life [17].

Conclusion

The results of this study exhibited that in children with cystic fibrosis, the sinonasal quality of life has a significant relationship with the absence of chronic rhinosinusitis. According to the information analysis, this study showed that children with chronic rhinosinusitis had significantly lower sinonasal quality of life than children without chronic rhinosinusitis. From the SN-5 variable factors of sinus infection, nasal obstruction, and allergy symptoms, the quality of life score was significantly higher in patients with chronic rhinosinusitis than in those who did not have chronic rhinosinusitis. The findings of this study are important for improving children’s health related quality of life, as it leads to promoting communication between the patient and the health care provider, identifying overlooked problems, monitoring the progress of the disease and the burden of treatment, and promoting interventions in the daily life of patients.

  1. Funding: Research reported in this publication was supported by a grant [number: 13688] from the Shahid Beheshti University of Medical Sciences.

  2. Conflict of interest: The authors state no conflict of interest.

Acknowledgements

The researchers would like to express their gratitude to Research and Technology Deputy of Shahid Beheshti University of Medical Sciences.

Appendix

References

1 Ohn M, Robinson P, Selvadurai H, Fitzgerald DA. Question 11: How should Allergic Bronchopulmonary Aspergillosis [ABPA] be managed in Cystic Fibrosis? Paediatric respiratory reviews. 2017;24:35-8.10.1016/j.prrv.2016.10.001Suche in Google Scholar PubMed

2 Edwards E, Gosling S, Kansra S, O’Reilly R, West N. 403 Are cystic fibrosis (CF) healthcare professionals able to assess patient activation measures (PAM) in parents of children with CF? Journal of Cystic Fibrosis. 2017;16:S164-S5.10.1016/S1569-1993(17)30733-6Suche in Google Scholar

3 Hassanzad M, Orooji A, Valinejadi A, Velayati A. A fuzzy rule-based expert system for diagnosing cystic fibrosis. Electronic physician. 2017;9(12):5974.10.19082/5974Suche in Google Scholar PubMed

4 Chan DK, McNamara S, Park JS, Vajda J, Gibson RL, Parikh SR. Sinonasal quality of life in children with cystic fibrosis. JAMA Otolaryngology–Head & Neck Surgery. 2016;142(8):743-9.10.1001/jamaoto.2016.0979Suche in Google Scholar PubMed

5 Gysin C, Alothman G, Papsin B. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatric pulmonology. 2000;30(6):481-9.10.1002/1099-0496(200012)30:6<481::AID-PPUL8>3.0.CO;2-NSuche in Google Scholar PubMed

6 Tandon R, Derkay C, head, surgery n. Contemporary management of rhinosinusitis and cystic fibrosis. Current opinion in otolaryngology. 2003;11(1):41-4.10.1097/00020840-200302000-00009Suche in Google Scholar

7 King VvB. Upper respiratory disease, sinusitis, and polyposis. Clinical reviews in allergy. 1991;9(1-2):143.10.1007/BF02914539Suche in Google Scholar PubMed

8 Stern RC, Boat TF, Wood RE, Matthews LW, Doershuk CF. Treatment and prognosis of nasal polyps in cystic fibrosis. American journal of diseases of children. 1982;136(12):1067-70.10.1001/archpedi.1982.03970480033008Suche in Google Scholar

9 Friedman EM, Stewart M. An assessment of sinus quality of life and pulmonary function in children with cystic fibrosis. American journal of rhinology. 2006;20(6):568-72.10.2500/ajr.2006.20.2915Suche in Google Scholar PubMed

10 Kay DJ, Rosenfeld RM, Surgery N. Quality of life for children with persistent sinonasal symptoms. Journal of Otolaryngology - Head & Neck Surgery. 2003;128(1):17-26.10.1067/mhn.2003.41Suche in Google Scholar

11 Rudnick EF, Mitchell RB. Long-term improvements in quality-of-life after surgical therapy for pediatric sinonasal disease. Otolaryngology–Head & Neck Surgery. 2007;137(6):873-7.10.1016/j.otohns.2007.08.006Suche in Google Scholar PubMed

12 Sahu N, Mohapatra SSG, Rath SN, Padhy RN. Radiological significance of isolated Ethmoid sinus infections in asymptomatic patients of recurrent acute rhinosinusitis. International Journal of Research in Medical Sciences. 2017;5(5):1781-4.10.18203/2320-6012.ijrms20171520Suche in Google Scholar

13 Ziari A, Ansari M, Valinejadi A. The gap between the service quality and patients’ expectations in amir-al-momenin hospital of Semnan university of medical sciences in 2016, Semnan, Iran. Koomesh. 2018:221-7.Suche in Google Scholar

14 Ansari M, Mohammad-Moradi F, Khaledian M, Shekofteh M, Valinejadi A. Assessment Of Health Literacy Level In 18-30 Year-Old Adults, An Iranian Experience. Library Philosophy and Practice (e-journal). 2018;7.Suche in Google Scholar

15 Møller ME, Alanin MC, Grønhøj C, Aanoes K, Høiby N, von Buchwaldm C. Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review. American journal of rhinology allergy. 2017;31(5):293-8.10.2500/ajra.2017.31.4461Suche in Google Scholar PubMed PubMed Central

16 Pinart M, Keller T, Reich A, Fröhlich M, Cabieses B, Hohmann C, et al. Sex-related allergic rhinitis prevalence switch from childhood to adulthood: a systematic review and meta-analysis. International archives of allergy immunology. 2017;172(4):224-35.10.1159/000464324Suche in Google Scholar PubMed

17 Habib A-RR, Buxton JA, Singer J, Wilcox PG, Javer AR, Quon BS. Association between chronic rhinosinusitis and health-related quality of life in adults with cystic fibrosis. Annals of the American Thoracic Society. 2015;12(8):1163-9.10.1513/AnnalsATS.201504-191OCSuche in Google Scholar PubMed

Received: 2019-02-06
Accepted: 2019-03-09
Published Online: 2019-06-17

© 2019 Maryam Hassanzad et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Research Article
  2. ATP Synthase: Structure, Function and Inhibition
  3. Insulin Promotes Wound Healing by Inactivating NFkβP50/P65 and Activating Protein and Lipid Biosynthesis and alternating Pro/Anti-inflammatory Cytokines Dynamics
  4. Mini review
  5. The disordered boundary of the cell: emerging properties of membrane-bound intrinsically disordered proteins
  6. Research Article
  7. Expression of OX40 Gene and its Serum Levels in Neuromyelitis Optica Patients
  8. Advances in Molecular biomarker for early diagnosis of Osteoarthritis
  9. Identification of BRCA1/2 p.Ser1613Gly, p.Pro871Leu, p.Lys1183Arg, p.Glu1038Gly, p.Ser1140Gly, p.Ala2466Val, p.His2440Arg variants in women under 45 years old with breast nodules suspected of having breast cancer in Burkina Faso
  10. Endometriosis Pathoetiology and Pathophysiology: Roles of Vitamin A, Estrogen, Immunity, Adipocytes, Gut Microbiome and Melatonergic Pathway on Mitochondria Regulation
  11. Integral membrane protein expression of human CD25 on the cell surface of HEK293 cell line: the available cellular model of CD25 positive to facilitate in vitro developing assays
  12. Review Article
  13. Role of Nanomedicine in Redox Mediated Healing at Molecular Level
  14. Research Article
  15. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) variants and breast cancer risk in Burkina Faso
  16. Incidence of viruses infecting pepper in Thailand
  17. Mechanochemistry of von Willebrand factor
  18. Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways
  19. Role of Killer cell immunoglobulin-like receptors (KIR) genes in stages of HIV-1 infection among patients from Burkina Faso
  20. The effect of rs9930506 FTO gene polymorphism on obesity risk: a meta-analysis
  21. Special Issue: Recent Advances in Basic and Clinical Medicine
  22. Antihyperglycemic and antihyperlipidemic activities of Nannochloropsis oculata microalgae in Streptozotocin-induced diabetic rats
  23. Comparison of the effect of vitamin D on osteoporosis and osteoporotic patients with healthy individuals referred to the Bone Density Measurement Center
  24. Zinc enhances the expression of morphine-induced conditioned place preference through dopaminergic and serotonergic systems
  25. Pre-operative laparoscopic staging of gastric cancer in patients who are candidates for neo-adjuvant chemotherapy: A Cross Sectional Study
  26. Neurotoxic Effects of Stanozolol on Male Rats‘ Hippocampi: Does Stanozolol cause apoptosis?
  27. Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer
  28. Evaluation of Quality of Life in Terms of Sinonasal Symptoms in Children with Cystic Fibrosis
  29. The Effect of Fine needle aspiration on Detecting Malignancy in Thyroid Nodule
  30. Diagnosis of Primary Hydatid Cyst of Thyroid Gland: A Case Report
  31. Ultrasonography in the diagnosis of lung adhesion before surgery
Heruntergeladen am 22.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/bmc-2019-0011/html
Button zum nach oben scrollen